<DOC>
	<DOCNO>NCT02901587</DOCNO>
	<brief_summary>The purpose study investigate effect Lu AF35700 electrical activity heart measure electrocardiogram ( ECG ) patient schizophrenia schizoaffective disorder 6 week treatment</brief_summary>
	<brief_title>Study Investigating Effect Lu AF35700 Cardiac Repolarization Men Women With Schizophrenia Schizoaffective Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>The patient able her/himself provide inform consent participate study The patient primary diagnosis schizophrenia schizoaffective disorder ( DSM5™ criterion ) The patient BMI ≤35 kg/m2 The patient Clinical Global Impression Severity Illness ( CGIS ) score ≤4 ( moderately ill ) PANSS total score ≤ 80 score ≤4 ( moderate ) PANSS item , P7 ( hostility ) G8 ( uncooperativeness ) The patient willing hospitalize 8 week The patient generally healthy base medical history , physical examination , vital sign , ECG , laboratory test . The patient agree protocoldefined use effective contraception ´ The patient experience acute exacerbation psychosis require hospitalization within last 3 month require change medication due exacerbation psychosis within last 8 week The patient meet moderate severe comorbid Substance Abuse Disorder DSM5™ criterion last 3 month The patient significant risk harm her/himself others opinion investigator accord Columbia Suicide Severity Rating Scale ( CSSRS ) The patient test positive human immunodeficiency virus ( HIV ) , hepatitis B surface antigen ( HBsAg ) , hepatitis C virus antibody ( antiHCV ) Other protocol define inclusion exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>